ACCUEIL - Special-BIO-2018-Programme - Special-BIO-2018-Communiques-de-presse

Communiqués de presse

La Healthtech française en force à la Convention Internationale BIO

4è European Biotech & Medtech Investor Day - Boston, 4 juin 2018

France Biotech, l’association française des Entrepreneurs des Sciences de la Vie, organise le 4 juin à Boston, le 4è Investor Day, en avant-première de la Convention BIO, rendez-vous annuel international des sciences de la vie. Cet évènement est intégré à la journée organisée par Business France, dédiée à l’attractivité de la France pour développer des innovations en santé.

Read more HERE

----------------------------------------

4thInvestorDay – Boston, June 4th2018

The HealthTech sector meets American investors

Considering the major global public health challenges, the Healthtech sector, bringing together disruptive innovations in Biotech, Medtech and European Digital Tech, will present a selection of its most promising companies to American investors specialized in healthcare.

For Maryvonne Hiance, Chairman of France Biotech: “The scientific and technological excellence of French HealthTech, associated with our world-class healthcare system and environment, contributes to making Europe the most attractive region in terms of investments. The sector must quickly lift barriers, including funding, for its further development. That is the reason why this 4thInvestor Day in Boston, where a real French life Science hub is located with French researchers and entrepreneurs, is an opportunity to present our potential to healthcare-focused US investment funds.”

Read more HERE